Skip to main content
Clinical Trials/IRCT20171112037409N1
IRCT20171112037409N1RecruitingPhase 3

Evaluation the effectiveness of Ziziphus spina-christi topical solution plus clindamycin 1% compared with Clindamycin1% plus placebo in mild to moderate acne

Iran University of Medical Sciences0 sites110 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Recruiting
Enrollment
110

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
15 years to 45 years (—)
Sex
All

Inclusion Criteria

  • Subjects in age of 15 to 45 years old
  • Chief complaint: mild to moderate Acne vulgaris
  • subject willingness of herbal topical medicines use

Exclusion Criteria

  • History of polycyctic ovary
  • use of acnegenic medications such as corticosteroid, hurmonal or anti-psychotic medications
  • mechanical acne and gram-negative folliculitis
  • History of dermal allergy

Investigators

Similar Trials